JOSÉ ANTONIO RAMOS ATANCE-rekin lankidetzan egindako argitalpenak (5)

2011

  1. Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ 9-THCV in animal models of Parkinson's disease

    British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1495-1506

2009

  1. Relación del sistema cannabinoide con la fisiopatología y el tratamiento de la esquizofrenia

    Actualización sobre el potencial terapéutico de los cannabinoides (Sociedad Española de Investigación en Cannabinoides (SEIC)), pp. 239-256

2008

  1. Role of CB2 receptors in neuroprotective effects of cannabinoids

    Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2 SUPPL. 1

2007

  1. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

    Brain Research, Vol. 1134, Núm. 1, pp. 162-170

2006

  1. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

    Brain Research, Vol. 1073-1074, Núm. 1, pp. 209-219